Group President, Pfizer Biopharmaceuticals Group
Angela Hwang is a member of Pfizer’s Executive Team and Group President of the Pfizer Biopharmaceuticals Group, which is the commercial organization of Pfizer. Her organization of 26,000 colleagues across 125 countries is responsible for bringing over 600 innovative medicines and products to patients. In 2021, more than 1.4 billion people benefited from Pfizer medicines or vaccines to improve their health and, in some cases, save their lives. Angela is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa defined her worldview and underscored the importance of equity in everything she does today. Angela received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and her MBA from Cornell University, where she remains a Member of the Advisory Council of the SC Johnson Graduate School of Business. She is a wife and proud mom to a teenage son and daughter, and a strong advocate for women’s leadership and sustainable global health equity.